Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Safety Study of Duloxetine Hydrochloride in the Treatment of Japanese Children and Adolescents With Depressive Disorder

NCT03395353 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT03395353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Safety Study of Duloxetine Hydrochloride in the Treatment of Japanese Children and Adolescents With Depressive Disorder
Lead sponsor
Shionogi
Phase
Phase 3
Overall status
Terminated
Start date
January 29, 2018
Completion date
July 4, 2020
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder